Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment. Researchers at the Faculty of Pharmacy at the University have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of […]
The post A tailored and efficacious cancer vaccine platform appeared first on European Pharmaceutical Review.
Original Article: A tailored and efficacious cancer vaccine platform